Spots Global Cancer Trial Database for Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell Lymphoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell Lymphoma
Official Title: A Phase 2 Open-Label, Multicenter Study Evaluating The Safety And Efficacy of Axicabtagene Ciloleucel Concomitant With Prophylactic Steroids In Subjects With Relapsed Or Refractory Large B-Cell Lymphoma In The Outpatient Setting
Study ID: NCT05459571
Study Description
Brief Summary: The goal of this clinical study is to learn more about the study drug, axicabtagene ciloleucel, in participants with relapsed or refractory large B-cell lymphoma (LBCL) in the outpatient setting.
Detailed Description: Participants who complete at minimum 24 months follow up will be transitioned to a separate long-term follow-up study (study KT-US-982-5968) to complete the remainder of the 15-year follow-up assessments.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte, California, United States
UCLA, Los Angeles, California, United States
Colorado Blood Cancer Institute, Denver, Colorado, United States
University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, United States
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States
Oncology Hematology Care Clinical Trials, LLC, Cincinnati, Ohio, United States
Prisma Health - Upstate, Greenville, South Carolina, United States
Tennessee Oncology, PLLC, Nashville, Tennessee, United States
Henry-Joyce Cancer Clinic, Nashville, Tennessee, United States
Methodist Healthcare System of San Antonio, San Antonio, Texas, United States
Intermountain Healthcare, Murray, Utah, United States
Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States
University of Virginia Health System, Charlottesville, Virginia, United States
Virginia Oncology Associates, Norfolk, Virginia, United States
Virginia Commonwealth University, Richmond, Virginia, United States
Contact Details
Name: Kite Study Director
Affiliation: Kite, A Gilead Company
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
